Pediatric rheumatology

Groot N et al. Arthritis Rheumatol 2018. doi: 10.1002/art.40697

Seror R et al. Rheumatology (Oxford) 2018: key219. doi: 10.1093/rheumatology/key219

Luiz APL et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4200-5

In this review, Finch et al summarize and evaluate the current literature relating to vitamin D and juvenile idiopathic arthritis.

Finch SL, Rosenberg AM, Vatanparast H. Pediatr Rheumatol 2018; 16: 34. doi: 10.1186/s12969-018-0250-0

Yamato TP et al. Br J Sports Med 2018; 52: 1241–1245. doi: 10.1136/bjsports-2017-098927

Bovis F et al. Rheumatol Int 2018; 38(Suppl 1): 5–17. doi: 10.1007/s00296-018-3944-1

In a session at EULAR 2017 providing insights into juvenile idiopathic arthritis heterogeneity, EPOCA data were presented suggesting that geographic variability in JIA epidemiology, treatment, and outcomes may go some way to explaining it, while research deciphering the biologic basis of the condition could help combat it.

Malattia and Martini provide a comprehensive overview of juvenile idiopathic arthritis by discussing the etiopathogeneis, clinical presentation, and classification of this disease.

Malattia C, Martini A. In: Pediatric Rheumatology. Edited by Sawhney S, Aggarwal A.  Springer Science+Business Media Singapore, 2017. doi:10.1007/978-981-10-1750-6_17

In this chapter, the author provides an overview of the epidemiology of pediatric rheumatic diseases focusing primarily on juvenile idiopathic arthritis, which is the most common pediatric disease.

Manners PJ. In: Pediatric Rheumatology. Edited by Sawhney S, Aggarwal A.  Springer Science+Business Media Singapore, 2017. doi:10.1007/978-981-10-1750-6_5